John Rhodes to Heart Septal Defects, Atrial
This is a "connection" page, showing publications John Rhodes has written about Heart Septal Defects, Atrial.
Connection Strength
2.354
-
Combined prospective United States clinical study data for the GORE(?) HELEX(?) septal occluder device. Catheter Cardiovasc Interv. 2014 May 01; 83(6):944-52.
Score: 0.453
-
A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk. Catheter Cardiovasc Interv. 2013 Mar; 81(4):654-9.
Score: 0.416
-
Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis. 2007 Jul-Aug; 2(4):256-64.
Score: 0.287
-
Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure. Am Heart J. 2007 Apr; 153(4 Suppl):81-4.
Score: 0.282
-
The design and deployment of the HELEX septal occluder. Congenit Heart Dis. 2006 Sep; 1(5):202-9.
Score: 0.271
-
Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder. Am Heart J. 2006 May; 151(5):1129.e7-11.
Score: 0.265
-
Transcatheter interventions across an inferior vena cava filter. Catheter Cardiovasc Interv. 2003 Jul; 59(3):333-7.
Score: 0.217
-
Device closure of secundum atrial septal defects in infants weighing less than 8 kg. Pediatr Cardiol. 2014 Oct; 35(7):1124-31.
Score: 0.115
-
Right hemidiaphragmatic elevation with a right-to-left interatrial shunt through a patent foramen ovale: a case report and literature review. Chest. 2001 Dec; 120(6):2094-6.
Score: 0.049